CART19 Cells Treatment of MRD of B Cell Malignancies and Then Auto-HSCT

Clinical trial NCT03685786 · UNKNOWN

Trial details

NCT number: NCT03685786
Sponsor: Shenzhen Second People's Hospital
Status: UNKNOWN
Phase: Phase 1
Study type: INTERVENTIONAL

Leukemia, Lymphocytic, Acute, B-Cell Leukemia, Lymphocytic, Chronic, B-Cell Lymphoma, B-Cell

Start date: 2018-06-01
Primary completion: 2021-06-02
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.